IL7 and lymphopenia: Experimental attempts to attenuate lymphopenia included isolating lymphocytes before treatment with reinfusion upon treatment completion (which appeared feasible and safe, but not effective) (30), or administering interleukins (e.g., IL-2, IL-7, and IL-15) essential for lymphocyte proliferation and survival with promising results in pilot studies (31).